Public Alert No. 024/2025 – Recall of Amoxivue (Amoxicillin) 500mg Capsules due to significantly low Active Pharmaceutical Ingredient (API) content
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Amoxivue (Amoxicillin) 500mg, with NAFDAC NO: A4-100178 and Batch NO: 322584, manufactured by Sparsh Bio-Tech Pvt, Ltd. Note: Sparsh Bio-Tech has declared no relationship with the MAH- MedVue Pharmaceutical Ltd. A batch of Amoxivue capsules (Amoxicillin […]